Benign prostatic hyperplasia: a new metabolic disease? (Q38181426)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458832%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Benign prostatic hyperplasia: a new metabolic disease? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458832%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

main subject

prostatic hypertrophy

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458832%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Mauro Gacci

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458832%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Gianni Forti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458832%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

G Rastrelli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458832%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

G Corona

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458832%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

M Maggi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458832%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

24 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458832%20AND%20SRC:MED&resulttype=core&format=json

Journal of Endocrinological Investigation

6 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458832%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458832%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458832%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

313-322

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458832%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s40618-014-0051-3

6 March 2020

exact match

0 references

cites work

Pre-clinical evidence and clinical translation of benign prostatic hyperplasia treatment by the vitamin D receptor agonist BXL-628 (Elocalcitol).

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Vitamin D receptor agonists target static, dynamic, and inflammatory components of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Urinary bladder contraction and relaxation: physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Chronic inflammation in the pathogenesis of benign prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Recent studies on the mechanism of action of testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Risk stratification for benign prostatic hyperplasia (BPH) treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Current status of 5alpha-reductase inhibitors in the management of lower urinary tract symptoms and BPH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Epidemiology, diagnosis, and treatment of male hypogonadotropic hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Enzymes of Androgen Formation and Degradation in the Human Prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Concurrent improvement of the metabolic syndrome and lower urinary tract symptoms upon normalisation of plasma testosterone levels in hypogonadal elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Beneficial effects of testosterone administration on symptoms of the lower urinary tract in men with late-onset hypogonadism: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Testosterone supplementation does not worsen lower urinary tract symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Testosterone replacement alone for testosterone deficiency syndrome improves moderate lower urinary tract symptoms: one year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Serum PSA as a predictor of testosterone deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: a role for GPR30/GPER?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Androgens and estrogens in benign prostatic hyperplasia: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Sex steroid receptors in male human bladder: expression and biological function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Sex-hormone-induced inflammation and fibromuscular proliferation in the rat lateral prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Expression of proinflammatory genes during estrogen-induced inflammation of the rat prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Association between lower urinary tract symptoms and serum levels of sex hormones in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Associations between longitudinal changes in serum estrogen, testosterone, and bioavailable testosterone and changes in benign urologic outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Risk factors for progression or improvement of lower urinary tract symptoms in a prospective cohort of men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Progestin receptors: isoforms and antihormone action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Human benign prostatic hyperplasia stromal cells as inducers and targets of chronic immuno-mediated inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

The benign prostatic hyperplasia registry and patient survey: study design, methods and patient baseline characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Body mass index and risk of BPH: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Interleukin 8 and the male genital tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Body mass index and risk of prostate cancer in U.S. health professionals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Metabolic factors associated with benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Androgen regulation of prostate cancer: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

The correlation between metabolic syndrome and prostatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Metabolic syndrome and lower urinary tract symptoms: the role of inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Mechanism of action of phosphodiesterase type 5 inhibition in metabolic syndrome-associated prostate alterations: an experimental study in the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

PDE5 inhibitors blunt inflammation in human BPH: a potential mechanism of action for PDE5 inhibitors in LUTS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Metabolic syndrome induces inflammation and impairs gonadotropin-releasing hormone neurons in the preoptic area of the hypothalamus in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0051-3

Effect of long-term oral testosterone undecanoate treatment on prostate volume and serum prostate-specific antigen concentration in eugonadal middle-aged men

21 January 2018

1 reference

12 December 2020

Elevated body mass index correlates with higher seminal plasma interleukin 8 levels and ultrasonographic abnormalities of the prostate in men attending an andrology clinic for infertility

1 reference

12 December 2020

Endocrine status in elderly men with lower urinary tract symptoms: correlation of age, hormonal status, and lower urinary tract function. The Prostate Study Group of the Austrian Society of Urology

1 reference

12 December 2020

Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia

1 reference

12 December 2020

Effects of age, sex steroids, and family relationships on volumes of prostate zones in men with and without prostate cancer

1 reference

12 December 2020

Associations of obesity with lower urinary tract symptoms and noncancer prostate surgery in the Third National Health and Nutrition Examination Survey

1 reference

12 December 2020

Evaluation of the bacterial flora of the prostate using a 16S rRNA gene based polymerase chain reaction

1 reference

12 December 2020

Changes in dihydrotestosterone metabolism and the development of benign prostatic hyperplasia in the aging beagle

1 reference

12 December 2020

Metabolic syndrome and prostate abnormalities in male subjects of infertile couples

1 reference

12 December 2020

Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls

1 reference

12 December 2020

Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.

1 reference

12 December 2020

The development of human benign prostatic hyperplasia with age

1 reference

12 December 2020

The prostate-associated lymphoid tissue (PALT) is linked to the expression of homing chemokines CXCL13 and CCL21

1 reference

12 December 2020

Estradiol up-regulates estrogen receptor and progesterone receptor gene expression in specific ovine uterine cells

1 reference

12 December 2020

Hypogonadism and metabolic syndrome

1 reference

12 December 2020

Effects of testosterone supplementation in the aging male

1 reference

12 December 2020

Patterns of Inflammation in Prostatic Hyperplasia: A Histologic and Bacteriologic Study

1 reference

12 December 2020

Influence of Age and Endocrine Factors on the Volume of Benign Prostatic Hyperplasia

1 reference

12 December 2020

Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B

1 reference

12 December 2020

The Endocrine Control of the Prostate: (Section of Urology).

1 reference

12 December 2020

Serum sex steroid hormones and lower urinary tract symptoms in Third National Health and Nutrition Examination Survey (NHANES III)

1 reference

12 December 2020

LUTS, BPH, BPE, BPO: A Plea for the Logical Use of Correct Terms

1 reference

12 December 2020